Petros Pharmaceuticals Announces Closing of $7.5 Million Offering

Investors included the company's largest shareholder NEW YORK, Dec. 28, 2021 Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced the closing of its previously announced registered direct offe... Biopharmaceuticals, Venture Capital Petros Pharmaceuticals, erectile dysfunction, endothelial dysfunction
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news